$0.9594
0.009400.99%
At close: -
$0.9895
0.033.14%
After Hours: 7:53 PM EDT
Comments
Loading...
Lineage Cell Therapeutics Stock Guidance | AMEX:LCTX | Benzinga
Lineage Cell Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lineage Cell Therapeutics Inc (LCTX) does not provide guidance data | ||||||||||||
FAQ
What is the most recent guidance for Lineage Cell Therapeutics (LCTX)?
There have been no specific sales or earnings guidance reported for Lineage Cell Therapeutics in recent months.
Browse guidance and forecast on all stocks.
